Evidence map›Paper›PMID 35008726›Full record

ArticleInternational journal of molecular sciences2021

T-Cell Response against Varicella Zoster Virus in Patients with Multiple Sclerosis during Relapse and Remission.

Miriam Pérez-Saldívar, Graciela Ordoñez, Benjamín Pineda, Julio Sotelo, Adolfo Martínez-Palomo, José Flores-Rivera, Martha Espinosa-Cantellano

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Miriam Pérez-SaldívarDepartment of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies (Cinvestav), Mexico City 07360, Mexico.
Graciela OrdoñezDepartment of Neuroimmunology, National Institute of Neurology and Neurosurgery "Manuel Velasco Suarez" (INNN), Mexico City 14269, Mexico.ORCID 0000-0003-3931-5213
Benjamín PinedaDepartment of Neuroimmunology, National Institute of Neurology and Neurosurgery "Manuel Velasco Suarez" (INNN), Mexico City 14269, Mexico.ORCID 0000-0002-1455-312X
Julio SoteloDepartment of Neuroimmunology, National Institute of Neurology and Neurosurgery "Manuel Velasco Suarez" (INNN), Mexico City 14269, Mexico.
Adolfo Martínez-PalomoDepartment of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies (Cinvestav), Mexico City 07360, Mexico.
José Flores-RiveraClinical Laboratory of Neurodegenerative Diseases, National Institute of Neurology and Neurosurgery "Manuel Velasco Suarez" (INNN), Mexico City 14269, Mexico.
Martha Espinosa-CantellanoDepartment of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies (Cinvestav), Mexico City 07360, Mexico.

Funding

Consejo Nacional de Ciencia y Tecnología CB-2016-01-287347Consejo Nacional de Ciencia y Tecnología SALUD-2015-1-261698Consejo Nacional de Ciencia y Tecnología Scholarship number 481492Mexican Ministry of Education SEP-Cinvestav_FIDSC2018-17Miguel Alemán Foundation Support for Research Activities
6 · The paper itself

Abstract

An association between varicella zoster virus (VZV) and multiple sclerosis (MS) has been reported in Mexican populations. The aim of this study was to compare the response of T cells from MS patients, during relapse and remission, to in vitro stimulation with VZV, adenovirus (AV) and Epstein-Barr virus (EBV). Proliferation and cytokine secretion of T cells from 29 relapsing-remitting MS patients and 38 healthy controls (HC) were analyzed by flow cytometry after stimulating with VZV, AV or EBV. IgG and IgM levels against VZV and EBV were quantified using Enzyme-Linked Immunosorbent Assay. Relapsing MS patients showed a higher percentage of responding CD4+ and CD8+ T cells against VZV compared to AV. In HC and remitting MS patients, proliferation of CD4+ T cells was higher when stimulated with VZV as compared to EBV. Moreover, T cells isolated from remitting patients secreted predominantly Th1 cytokines when cell cultures were stimulated with VZV. Finally, high concentration of anti-VZV IgG was found in sera from patients and controls. The results support previous studies of an VZV-MS association in the particular population studied and provide additional information about the possible role of this virus in the pathogenesis of MS.

Indexed as

AdenoviridaeAdultAntibodies, ViralCytokinesFemaleHerpesvirus 3, HumanHerpesvirus 4, HumanHumansImmunoglobulin GImmunoglobulin MMaleMultiple SclerosisMultiple Sclerosis, Relapsing-RemittingRecurrenceRemission InductionT-LymphocytesAntibodies, ViralCytokinesImmunoglobulin GImmunoglobulin Mautoimmune diseasemultiple sclerosisvirus

Identifiers

PMID35008726
PMCPMC8745673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.